125 related articles for article (PubMed ID: 21162801)
21. Cystogenic potential of CD133+ progenitor cells of human polycystic kidneys.
Carvalhosa R; Deambrosis I; Carrera P; Pasquino C; Rigo F; Ferrari M; Lasaponara F; Ranghino A; Biancone L; Segoloni G; Bussolati B; Camussi G
J Pathol; 2011 Sep; 225(1):129-41. PubMed ID: 21706482
[TBL] [Abstract][Full Text] [Related]
22. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo.
Popa ER; Harmsen MC; Tio RA; van der Strate BW; Brouwer LA; Schipper M; Koerts J; De Jongste MJ; Hazenberg A; Hendriks M; van Luyn MJ
J Mol Cell Cardiol; 2006 Jul; 41(1):86-96. PubMed ID: 16780869
[TBL] [Abstract][Full Text] [Related]
23. CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood.
Pelagiadis I; Relakis K; Kalmanti L; Dimitriou H
Cytotherapy; 2012 Jul; 14(6):701-6. PubMed ID: 22413760
[TBL] [Abstract][Full Text] [Related]
24. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.
Jung C; Rafnsson A; Shemyakin A; Böhm F; Pernow J
Int J Cardiol; 2010 Sep; 143(3):368-72. PubMed ID: 19398138
[TBL] [Abstract][Full Text] [Related]
25. CD133+ renal progenitor cells contribute to tumor angiogenesis.
Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G
Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683
[TBL] [Abstract][Full Text] [Related]
26. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance.
Bussolati B; Moggio A; Collino F; Aghemo G; D'Armento G; Grange C; Camussi G
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F116-28. PubMed ID: 21900452
[TBL] [Abstract][Full Text] [Related]
28. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes.
Perrella G; Brusini P; Spelat R; Hossain P; Hopkinson A; Dua HS
Br J Ophthalmol; 2007 Jan; 91(1):94-9. PubMed ID: 16956910
[TBL] [Abstract][Full Text] [Related]
29. In vitro identification of a cord blood CD133+CD34-Lin+ cell subset that gives rise to myeloid dendritic precursors.
Goussetis E; Theodosaki M; Paterakis G; Tsecoura C; Graphakos S
Stem Cells; 2006 Apr; 24(4):1137-40. PubMed ID: 16339995
[No Abstract] [Full Text] [Related]
30. Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice.
Burger D; Gutsol A; Carter A; Allan DS; Touyz RM; Burns KD
Nephrol Dial Transplant; 2012 Oct; 27(10):3781-9. PubMed ID: 22561581
[TBL] [Abstract][Full Text] [Related]
31. Segmental heterogeneity in Bcl-2, Bcl-xL and Bax expression in rat tubular epithelium after ischemia-reperfusion.
Valdés F; Pásaro E; Díaz I; Centeno A; López E; García-Doval S; González-Roces S; Alba A; Laffon B
Nephrology (Carlton); 2008 Jun; 13(4):294-301. PubMed ID: 18221257
[TBL] [Abstract][Full Text] [Related]
32. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
[TBL] [Abstract][Full Text] [Related]
33. In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy.
Zhang Y; Wong S; Laflèche J; Crowe S; Mesana TG; Suuronen EJ; Ruel M
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):216-24, 224.e1-4. PubMed ID: 20167338
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
[TBL] [Abstract][Full Text] [Related]
35. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.
Florek M; Haase M; Marzesco AM; Freund D; Ehninger G; Huttner WB; Corbeil D
Cell Tissue Res; 2005 Jan; 319(1):15-26. PubMed ID: 15558321
[TBL] [Abstract][Full Text] [Related]
36. Increased circulating progenitor cells in Alzheimer's disease patients with moderate to severe dementia: evidence for vascular repair and tissue regeneration?
Stellos K; Panagiota V; Sachsenmaier S; Trunk T; Straten G; Leyhe T; Seizer P; Geisler T; Gawaz M; Laske C
J Alzheimers Dis; 2010; 19(2):591-600. PubMed ID: 20110604
[TBL] [Abstract][Full Text] [Related]
37. CD133 expressing pericytes and relationship to SDF-1 and CXCR4 in spinal cord injury.
Graumann U; Ritz MF; Rivero BG; Hausmann O
Curr Neurovasc Res; 2010 May; 7(2):144-54. PubMed ID: 20374199
[TBL] [Abstract][Full Text] [Related]
38. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
[TBL] [Abstract][Full Text] [Related]
39. [Effect of bone marrow mesenchymal stem cells
on angiogenesis in rats after brain injury].
Hu W; Liu J; Jiang J; Yang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):489-95. PubMed ID: 27269923
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of B/K protein expression in proximal and distal tubules of rat kidneys with ischemia-reperfusion injury.
Han KH; Lee UY; Jang YS; Cho YM; Jang YM; Hwang IA; Ghee JY; Lim SW; Kim WY; Yang CW; Kim J; Kwon OJ
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F100-6. PubMed ID: 16896191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
